Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Term Colchicine Steady-State Levels in Chronic Kidney Disease: Pharmacokinetic Profile and Potential Toxicity Risk (Hemodialysis Subtopic)
TCTR20250921005Not yet recruiting
- Sponsor
- Faculty of Medicine, Naresuan University
- Start
- Nov 2025
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of colchicine in chronic kidney disease (CKD) and end-stage kidney disease (ESKD), sponsored by Faculty of Medicine, Naresuan University. Primary endpoints: Steady-state colchicine pharmacokinetic parameters and Colchicine-related toxicity risk. Planned start Nov 2025; status: not yet recruiting.
02
Drugs
colchicine
03
Conditions
chronic kidney disease (CKD)end-stage kidney disease (ESKD)
Beyond the preview
Go deeper on TCTR20250921005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250921005.